| Patient | Natsume Sōseki |
|---|---|
| Date of birth | 1983-02-09 |
| Identifiers | MRN HR-ET023-SYN; SSN (made up) 000-23-8840 |
| Document date | 2026-06-16 |
| Author | Haruka Lindqvist-Mori, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Mr. Natsume is a 43-year-old novelist with a gastric ulcer and Helicobacter pylori infection diagnosed four weeks ago, on vonoprazan and oral iron, who comes for the preventive visit booked at his first appointment. He finishes the eradication course tomorrow. His stomach pain has gone and he has had no black, tarry stools since before the endoscopy; the iron makes his stools dark but formed. His back is much better after five days of heat and walking, and he has needed acetaminophen only twice. He is close to the end of the newspaper serial and is pacing himself. He has no new concerns. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 43 |
| Ulcer | Pain gone; eradication therapy ends tomorrow |
| Back | Much better |
| Mood | PHQ-2 1; less pressed by the serial |
Health risk assessment. Completed by the patient on paper in the waiting room and reviewed with him by Dr. Lindqvist-Mori. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Fair, improving |
| Psychosocial | Work deadlines are his main stress; supportive household and friends |
| Substance use | AUDIT-C 1; no NSAIDs since his first visit; no drug use |
| Tobacco | Does not smoke |
| Physical activity | Walks most evenings, about 30 minutes |
| Nutrition | Rice, fish, vegetables and pickles; sweets most days; meals often late |
| Sleep | Six hours, better since the pain went |
| Safety | Wears a seat belt; no firearm at home; feels safe at home |
| Sexual health | One partner; no concerns |
| Activities of daily living | Independent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or weight loss |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing loss; metallic taste from the antibiotics |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No epigastric pain, vomiting or black, tarry stools; dark formed stools on iron |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Positive | Mild low back stiffness, improving |
| Integumentary | Negative | No rash or changing moles |
| Endocrine | Negative | No thirst or frequent urination |
| Psychiatric | Negative | Mood good; PHQ-2 1 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for headache or pain, no more than 3 g a day (in place of ibuprofen) | One or two tablets every six hours as needed; no more than six tablets a day | Oral route | 2026-05-18 | active | S |
| Vonoprazan 20 mg oral tablet, one tablet by mouth each morning for eight weeks for gastric ulcer healing | One tablet each morning for eight weeks | Oral route | 2026-05-21 to 2026-07-16 | completed | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning | Oral route | 2026-05-21 | active | S |
| Vonoprazan 20 mg oral tablet, one extra tablet by mouth each evening for 14 days during eradication therapy (20 mg twice daily with the morning dose) | One tablet each evening for 14 days | Oral route | 2026-06-04 to 2026-06-17 | completed | S |
| Amoxicillin 500 mg oral capsule, two capsules (1 g) by mouth three times daily for 14 days | Two capsules three times daily for 14 days | Oral route | 2026-06-04 to 2026-06-17 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-16 | Body height | 159 | cm | S |
| 2026-06-16 | Body weight | 52.6 | kg | S |
| 2026-06-16 | Body mass index (BMI) [Ratio] | 20.8 | kg/m2 | S |
| 2026-06-16 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-06-16 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-06-16 | Heart rate | 74 | /min | S |
| 2026-06-16 | Respiratory rate | 14 | /min | S |
| 2026-06-16 | Body temperature | 36.5 | Cel | S |
| 2026-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-16 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-06-16 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 2026-06-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.8 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes | High | S |
| 2026-06-16 | Cholesterol [Mass/volume] in Serum or Plasma | 186 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-06-16 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 56 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-06-16 | Triglyceride [Mass/volume] in Serum or Plasma | 96 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-06-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 111 | mg/dL | <=129 mg/dL | Normal | S |
Vital signs recorded on 2026-06-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 52.6 kg, BMI 20.8; blood pressure 120/76 |
| Skin | No suspicious moles; conjunctivae a little pale |
| Neck | Thyroid normal; no lymph nodes; no supraclavicular node |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear |
| Abdomen | Soft; no epigastric tenderness or mass; no enlarged liver |
| Back | Mild paraspinal tenderness only; full movement |
| Psychiatric | Engaged and good-humoured |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| About three weeks of gnawing epigastric pain, worse before meals and at night and eased by food, with two episodes of black, tarry stools ten days ago and iron-deficiency anemia; stable, Glasgow-Blatchford score 4; peptic ulcer suspected and urgent endoscopy booked | resolved | confirmed | R10.13 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its timing echoes his documented stomach illness of May 1910 (D). |
| Gastric ulcer, 15 mm, on the lesser curvature at the angulus, with recent bleeding (melena) and a clean base at endoscopy (Forrest III); margin biopsies benign; Helicobacter pylori positive; synthetic modern diagnosis for his documented gastric ulcer | active | confirmed | K25.4 | S — Synthetic modern diagnosis anchored to his documented gastric ulcer (D); the Helicobacter pylori cause is synthetic. |
| Helicobacter pylori infection (rapid urease test and histology positive; clarithromycin resistance mutation on biopsy PCR) | active | confirmed | B96.81 | S — Synthetic finding at endoscopy; no historical claim is made about the organism in his illness. |
| Iron-deficiency anemia from chronic blood loss (hemoglobin 11.2 g/dL, MCV 76 fL, ferritin 8 ng/mL) | active | confirmed | D50.0 | S — Synthetic finding at intake. |
| Acute low back strain after lifting a box of books, without red flags, managed without NSAIDs because of the gastric ulcer; resolved | active | confirmed | M54.50 | S — Synthetic intercurrent illness; not a historical claim. |
| Prediabetes (hemoglobin A1c 5.8%) | active | confirmed | R73.03 | S — Synthetic finding at the preventive visit; not a claim about his real health at this age. |
| Chronic atrophic gastritis from Helicobacter pylori, moderate atrophy with focal intestinal metaplasia in the antrum (OLGA stage II, OLIM stage I; open-type endoscopic atrophy); no dysplasia; yearly endoscopic surveillance | active | confirmed | K29.40 | S — Synthetic histology finding at the two-week visit; not a historical claim. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 120/76 mmHg |
| Depression screening | Completed today | PHQ-2 score 1 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Tobacco use | Completed today | Does not smoke |
| Lipid screening and statin assessment | Completed today | Total cholesterol 186, HDL 56, LDL 111 mg/dL; low ten-year risk; no statin |
| Diabetes screening | Completed today | A1c 5.8%: prediabetes; screened at a lower BMI because of Asian ancestry |
| Colorectal cancer screening | Not indicated | Begins at 45; colonoscopy sooner only if the anemia does not correct |
| Gastric cancer surveillance | Up to date | Endoscopy last month; repeat endoscopy in about seven weeks, then yearly for atrophy and intestinal metaplasia |
| HIV screening | Completed today | Once for adults 15 to 65; sent today |
| Hepatitis C screening | Completed today | Once for adults 18 to 79; sent today |
| Hepatitis B screening | Completed today | Once for all adults; sent today before the first vaccine dose |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap; no record of a booster within ten years |
| Hepatitis B vaccine | Completed today | Dose 1 of 2 today, dose 2 at the eleven-week review |
| Influenza vaccine | Due | In the autumn |
| COVID-19 vaccine | Due | Discuss in the autumn |
| Zoster vaccine | Not indicated | Begins at 50 |
| NSAID avoidance | Up to date | No NSAIDs since his first visit; acetaminophen for pain |
Immunizations given today: Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]
Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Prediabetes and Type 2 Diabetes: Screening (2021); Adult Immunization Schedule by Age (2026)
Follow-up: Eleven-week review with the urea breath test, repeat endoscopy, blood count, ferritin, PHQ-9 and the second hepatitis B dose. HIV, hepatitis B and C results by phone. Next preventive visit in one year. Next scheduled visit 2026-08-03: eleven-week review: urea breath test, repeat endoscopy for ulcer healing, anemia, and surveillance planning. [S]
Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants full treatment, including transfusion and endoscopic or surgical treatment, if the ulcer bleeds again. He named a health care agent, recorded in the confidential part of the chart and not named here, and chose not to record other treatment preferences today. To be revisited yearly. [S]